Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc. C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. The Company, through its wholly owned subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics.


CSE:COOL - Post by User

Bullboard Posts
Post by Stranius75on May 31, 2018 2:45pm
66 Views
Post# 28107133

Breaking news .... ooops that was over 2 years ago

Breaking news .... ooops that was over 2 years ago Keep drink g the koolaid pumpers ......hahahahahahahahahaha

LDS Receives Approval for Production

the company announced yesterday after market close to have received a permit to cultivate marijuana and manufacture marijuana products in a temporary mobile structure in the city of Coachella, California.

 

This provides LDS a place to manufacture its CannaStrips in the intermin period during the construction of a permanent 111,000 square foot permitted CTI building. The temporary facility allows LDS to produce its marijuana infused CannaStrips four to five months sooner, while waiting for the completion of the permanent building. LDS believes that this accelerated timeframe for opening the California market is a significant step in its brand recognition and first to market efforts for LDS.
Yesterday after market close, LDS has announced to have officially received a permit to cultivate marijuana and manufacture marijuana products.  As Danny has indicated, it‘s a company-making event. LDS is poised to now enter into a longer termed upward trend and pick up to other peers trading at much higher levels, or as Danny concluded. 
The CEO of LDS is Brad Eckenweiler and President is Jim Pakulis. In 2010 Mr. Eckenweiler and Mr. Pakulis oversaw a reserve merger and a $2.5m capital raise to create a newly formed entity, General Cannabis, Inc. The goal of General Cannabis was to identify, acquire and grow small medicinal cannabis related entities into meaningful positions. Mr. Pakulis was Chairman and CEO of General Cannabis. One of the entities identified and acquired was Weedmaps.com. At the time, Weedmaps was stagnant and generating less than $30,000 a month in revenue. Subsequent to the acquisition, and with the leadership of Mr. Pakulis and his team, Weedmaps began to grow exponentially to the point of generating approximately $2 million a month in revenue with an EBITDA greater than 25%. In 2012 General Cannabis generated close to $18 million in annual revenue. At the end of 2012 General Cannabis was the largest publicly traded entity with the highest revenue and greatest profit margins in the cannabis industry.«

Bullboard Posts